Literature DB >> 9172778

Expression purification and characterization of recombinant human inducible prostaglandin G/H synthase from baculovirus-infected insect cells.

H J George1, D E Van Dyk, R A Straney, J M Trzaskos, R A Copeland.   

Abstract

The inducible isoform of human prostaglandin G/H synthase (human cyclooxygenase; hCOX2) has been produced in Sf21 insect cells using the baculovirus expression system. The full-length gene for hCOX2 was placed under the control of the hybrid pCap/PolH promoter and recombinant virus generated by homologous recombination. Insect cells infected with recombinant virus synthesized active hCOX2 at levels exceeding 5% of total cellular protein 72 h postinfection. Optimal production on a preparative scale and high activity yields were attained in 8-liter spinner flasks using a supplemented Grace's medium containing 10% FCS. The apo-enzyme was purified to homogeneity by detergent extraction and ion exchange chromatography and functionally reconstituted with heme to form the holo-enzyme. The purified enzyme from insect cells was identified as hCOX2 by enzymatic activity, Western immunoassay, and N-terminal sequence analysis; the latter also indicated correct processing of the hCOX2 signal sequence. Insect recombinant hCOX2 displays high specific activity for both cyclooxygenase and peroxidase activities at levels indistinguishable from mammalian derived enzyme. Spectroscopic analysis suggests that the recombinant enzyme adopts native-like secondary and tertiary structure. The data presented here demonstrate that this system is capable of providing high yields of active enzyme for biochemical, biophysical, and pharmacological investigations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9172778     DOI: 10.1006/prep.1996.0003

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.

Authors:  Adegoke O Adeniji; Barry M Twenter; Michael C Byrns; Yi Jin; Mo Chen; Jeffrey D Winkler; Trevor M Penning
Journal:  J Med Chem       Date:  2012-02-15       Impact factor: 7.446

Review 2.  Prostaglandin H synthase: resolved and unresolved mechanistic issues.

Authors:  Ah-Lim Tsai; Richard J Kulmacz
Journal:  Arch Biochem Biophys       Date:  2009-09-01       Impact factor: 4.013

3.  Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.

Authors:  Andy J Liedtke; Adegoke O Adeniji; Mo Chen; Michael C Byrns; Yi Jin; David W Christianson; Lawrence J Marnett; Trevor M Penning
Journal:  J Med Chem       Date:  2013-03-13       Impact factor: 7.446

4.  Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.

Authors:  C N Serhan; C B Clish; J Brannon; S P Colgan; N Chiang; K Gronert
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

5.  Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

Authors:  Charles N Serhan; Song Hong; Karsten Gronert; Sean P Colgan; Pallavi R Devchand; Gudrun Mirick; Rose-Laure Moussignac
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.